These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6296489)

  • 1. [Major endocrine diseases].
    Kato T
    Nihon Rinsho; 1982; 40(9):2041-7. PubMed ID: 6296489
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypoaldosteronism].
    Villabona C; Pallares R; Capell S; Busquets E
    Rev Clin Esp; 1983 Feb; 168(4):221-8. PubMed ID: 6304822
    [No Abstract]   [Full Text] [Related]  

  • 3. On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder.
    Norby L; Mark AL; Kaloyanides GJ
    Clin Nephrol; 1976 Sep; 6(3):404-13. PubMed ID: 991467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)].
    Rössler R
    Dtsch Med Wochenschr; 1975 Nov; 100(47):2443-8. PubMed ID: 171132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperaldosteronism and the renin-angiotensin system].
    Torikai T; Maebashi M; Yoshinaga K; Katsushima I; Goto K
    Saishin Igaku; 1969 May; 24(5):1048-54. PubMed ID: 4309762
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of Bartter's syndrome with special referrence to the pathogenesis (author's transl)].
    Sasaki H; Higa K; Asano T; Hirahashi T; Okumura M; Kawasaki T; Eto T; Onoyama K; Takebayashi S
    Nihon Naika Gakkai Zasshi; 1977 Feb; 66(2):193-204. PubMed ID: 616811
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bartter's syndrome, a case report and some consideration on pathogenetic mechanism (author's transl)].
    Yamamoto T; Ogihara T; Kumahara Y; Okuda K; Omori S
    Nihon Naika Gakkai Zasshi; 1974 Sep; 63(9):1066-72. PubMed ID: 4474348
    [No Abstract]   [Full Text] [Related]  

  • 8. [Renin-angiotensin-aldosterone function tests].
    Haruyama K; Fukuchi S
    Nihon Rinsho; 1982; 40(9):1997-2002. PubMed ID: 6296488
    [No Abstract]   [Full Text] [Related]  

  • 9. [Variations in renin and aldosterone activity in a typical case of Barter syndrome. Influence of anti-aldosterones and sodium intake].
    Zech P; Pozet N; Sassard J; Leitienne P; Blanc N; Colon S; Berthoux F; Touraine JL; Traeger J
    J Urol Nephrol (Paris); 1974 Sep; 80(9):760-5. PubMed ID: 4463254
    [No Abstract]   [Full Text] [Related]  

  • 10. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
    J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Idiopathic hyperaldosteronism and the related dexamethasone suppressive hyperaldosteronism].
    Yasuda K; Miura K
    Nihon Naika Gakkai Zasshi; 1992 Apr; 81(4):517-22. PubMed ID: 1320089
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathophysiological aspects of the renin-angiotensin-aldosterone system].
    Oelkers W
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():145-56. PubMed ID: 349923
    [No Abstract]   [Full Text] [Related]  

  • 13. [Secondary hyperaldosteronism].
    Veyrat R; Muller AF; Mach RS
    Schweiz Med Wochenschr; 1968 Jan; 98(3):65-75. PubMed ID: 4299459
    [No Abstract]   [Full Text] [Related]  

  • 14. [Regulation of aldosterone secretion in patients with thyrotoxicosis. I. Role of the renin-angiotensin system and corticotropin in the development of secondary hyperaldosteronism in patients with thyrotoxicosis].
    Rybina LV; Natarov VV; Rom-Bugoslavskaia ES
    Probl Endokrinol (Mosk); 1983; 29(2):24-30. PubMed ID: 6304681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bartter's syndrome: a metabolic study.
    Ross D; Weber HP
    J Kans Med Soc; 1976 Sep; 77(9):378-82. PubMed ID: 965791
    [No Abstract]   [Full Text] [Related]  

  • 16. Aldosterone production after suppression of corticotropic secretory activity.
    Spark RF; Gordon SJ; Dale SL; Melby JC
    Arch Intern Med; 1968 Nov; 122(5):394-8. PubMed ID: 4301259
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of aldosterone secretion by the renin-angiotensin system and by corticotropin.
    Gross F
    Adv Intern Med; 1968; 14():281-339. PubMed ID: 4303034
    [No Abstract]   [Full Text] [Related]  

  • 18. An unexpected rise in plasma aldosterone to furosemide-upright test in primary aldosteronism due to aldosterone producing adenoma.
    Shigemasa C; Kouchi T; Yoshida A; Mashiba H
    J Med; 1991; 22(3):187-93. PubMed ID: 1663149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent data on the physiopathologic metabolism of aldosterone].
    Jayle MF; Legrand JC; Pasqualini JR
    Expos Annu Biochim Med; 1967; 28():163-96. PubMed ID: 4303008
    [No Abstract]   [Full Text] [Related]  

  • 20. [Secondary hyperaldosteronisms].
    Veyrat R; Muller AF; Mach RS
    Presse Med (1893); 1969 Feb; 77(6):189-90. PubMed ID: 4306684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.